Iopofosine I 131 Active in Treating Malignancies in the Brain; Confirmed Response in CNS Lymphoma Provides Additional Validation for Continued Development of Iopofosine in Multiple CNS Malignancies ...

Dr. Lakshmi Nayak, director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute, explained in an interview with ...

Central nervous system (CNS) lymphoma is a cancer that affects the lymphatic system in the brain or spinal cord. CNS is an aggressive lymphoma, which affects survival rates. CNS lymphoma is a rare ...

Dr. Kelley adds two decades of highly relevant drug development and regulatory strategy experience spanning oncology, rare diseases and CNSNewly formed executive team is committed to execution and ...

Rare disease day is observed annually on the last day of February to spread awareness on certain conditions that can impact on patients lives.

Each part of the nervous system uses internal checks and balances to regulate its activity, responding to various factors like mood, health status, and the external environment.¹ These regulatory ...